An effective treatment that’s made possible through research and dedication to continuous improvement.
Innovation, integrity, leadership and a genuine care for our customers – these are the drivers behind what we do at 4CYTE™. We are a research and development company committed to pioneering joint health research and exploration in our field, leading us to create innovative, groundbreaking products that drive change within our industry.
Since 2008, 4CYTE™ has undergone rigorous assessments in both laboratory and clinical trials to test its safety and efficacy. Many of these studies have been peer reviewed and published in leading veterinary journals with 4CYTE™ and Epiitalis® both demonstrating not only symptom modifying capabilities, but also disease modifying effects. 4CYTE™ has also been scientifically proven to be as effective at treating symptoms of osteoarthritis including pain and inflammation as NSAID.
Below, you’ll find a selection of our scientific highlights from a growing body of evidence that supports the safety and efficacy of 4CYTE™ and Epiitalis®. These excerpts have been highly summarized. If you are interested in learning, please visit our FAQ page or get in touch with our team.